Humana acquires Solstenen i Skåne AB
The acquisition strengthens Humana's offering in LARO operations. Through the acquisition, Humana strengthens its range of services, helping more people with healthcare needs and thus expanding its social contribution.
Solstenen offers drug-assisted treatments for opioid addiction for patients who meet the criteria for LARO treatment. The company is one of Skåne's largest private LARO providers and consists of five outpatient clinics: Lund, Helsingborg, Landskrona, Ängelholm and Höör. Solstenen possesses high competence and is among the providers in Skåne who have the longest experience. The company operates within free healthcare choice in Skåne and through their solid, qualitative work, they have continuously increased the number of enrolled patients since the start of operations in 2014. During their last financial year, Solstenen’s full-year revenues amounted to SEK 46 million.
- We are very pleased that Solstenen AB, which is a leading provider in LARO operations, becomes part of Humana and that we get the opportunity to develop together. Solstenen conducts a business of high quality and with a high level of competence among employees. Together, we have the ambition to be a provider that is a driving force in the development of LARO as a form of care, says Titti Lilja, Business Area Manager Individual and Family at Humana.
Charlotte Gedeon, who is currently CEO and chief physician in charge of the clinics, will remain in the business, focusing on her physician role.
- We are really looking forward to becoming a part of Humana because our operations complement each other, and we have a common view on the way of working with the patient in focus. We see many exciting development opportunities for the joint operations that will benefit the patients, says Peter and Charlotte Gedeon, owners of Solstenen.
Humana has today entered into an agreement to acquire all shares in Solstenen i Skåne AB, which is financed with cash. The transaction is subject to Region Skåne's acceptance of the transfer of operations and is expected to be finalised 1st of February 2023. The operations will be a part of the division for Healthcare services in Humana's business area Individual & Family. The acquisition is a part of Humana's investment in services within the Healthcare area.
For more information, please contact:
Titti Lilja, Business Area Manager Individual & Family, +46 70-265 43 54, email@example.com
Amelie Gustafsson, Head of Communications Individual & Family, +46 76-142 13 80, firstname.lastname@example.org
Ewelina Pettersson, Head of Investor Relations, +46 73-074 79 12, email@example.com
Humana is a leading Nordic care company providing services within individual and family care, personal assistance, elderly care and special service housing in accordance with LSS. Humana has 18,000 employees in Sweden, Norway, Finland and Denmark providing care for 9,000 individuals and working to achieve the vision “Everyone is entitled to a good life”. In 2021, Humana’s operating revenue was SEK 8,188m. Humana is listed on Nasdaq Stockholm and the company’s headquarters are located in Stockholm. Read more about Humana on: https://www.humanagroup.com/